Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00767533 · ClinicalTrials.gov registry record
Immunobiology of Cancer
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 84
- Enrollment target
NCT00767533: Clinical Trial study, sponsored by Stanford University.
NCT00767533 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 84 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00767533 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 84 participants
- Enrollment target
Study Summary
To learn whether or not an Interferon defect in cell signaling, recently discovered in immune cells from melanoma patients as well as breast cancer patients, is common to all cancers.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2008-10 |
| Est. Completion | 2011-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00767533
The ClinicalTrials.gov registry entry for NCT00767533 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00767533 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00767533 about?
NCT00767533 is a clinical study titled "Immunobiology of Cancer". To learn whether or not an Interferon defect in cell signaling, recently discovered in immune cells from melanoma patients as well as breast cancer patients, is common to all cancers.
What is the current status of trial NCT00767533?
This trial is currently terminated. The enrollment target is 84 participants. The study started on 2008-10. Estimated completion is 2011-10.
Who is sponsoring clinical trial NCT00767533?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.